WHWilliam F. Horn

William F. Horn

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


William F. Horn has a total of 29 co-authors. Here are the top co-authors by number of shared publications:

  • Nancy L. Keim

    US Department of Agriculture, ARS, Western Human Nutrition Research Center, Davis CA

    3 shared publications
  • Nancy L. Keim

    From the Division of Endocrinology, Clinical Nutrition, and Vascular Medicine, Department of Internal Medicine, University of California, Davis (DDM, FAT, and JCR), and the Western Human Nutrition Research Center, Agricultural Research Service, US Department of Agriculture, University of California, Davis (NLK and WFH)

    3 shared publications
  • Cedric H. L. Shackleton

    1 shared publication
  • Darshan S. Kelley

    U.S. Department of Agriculture/Western Human Nutrition Research Center University of California One Shields Ave Davis California 95616

    1 shared publication
  • Deborah D Motton

    Division of Endocrinology, Clinical Nutrition, and Vascular Medicine, Department of Internal Medicine, University of California, Davis, CA 95616, USA

    1 shared publication
  • Dennis Faix

    1 shared publication

Latest Publications

  • In polycystic ovary syndrome, adrenal steroids are regulated differently in the morning versus in response to nutrient intake

    by Dumindra Gurusinghe, Sharan Gill, Rogelio U. Almario, Jennifer Lee, William F. Horn, Nancy L. Keim, Kyoungmi Kim, Sidika E. Karakas


  • Open Access

    Postprandial monocyte activation in response to meals with high and low glycemic loads in overweight women

    by Deborah D Motton, Nancy L Keim, Fatima A Tenorio, William F Horn, John C Rutledge

    Background: Recent data show that atherosclerosis is initiated and perpetuated by inflammatory events. Activation of immune cells such as monocytes initiates inflammation, a key step in atherosclerosis. Objective: We hypothesize that a high–glycemic load meal activates inflammatory cells, and that this is mediated by elevated circulating triacylglycerol-rich lipoproteins. Design: Sixteen women [body mass index (in kg/m2): 25.7–29.6], aged 20–48 y, consumed meals with a high or a low glycemic load in a crossover fashion. Blood samples were collected before and up to 8 h after the meals. Samples were measured for glucose, insulin, triacylglycerols, and circulating cytokines, and expression of tumor necrosis factor α (TNF-α) and interleukin 1β (IL-1β) was measured by flow cytometry. Results: At 3.5 h after the test meals, we observed a significant increase in monocytes expressing TNF-α with both high–and low–glycemic load meals. Also, expression of IL-1β in monocytes tended to increase, but the change was not significant. The glycemic load of the meal did not influence circulating cytokines and had only a minimal effect on postprandial triacylglycerol concentrations despite marked postprandial changes in glycemia and circulating insulin concentrations. Conclusions: In the postprandial state, monocytes can be activated by both high–and low–glycemic load meals. The glycemic load of a single meal did not have a significant effect on the degree of activation of the monocytes in women who displayed only a modest increase in circulating triacylglycerols in response to test meals. Future studies should examine the effect of glycemic load in subjects who have a hyperlipemic response to dietary carbohydrate.


  • Restrained Eating Behavior and the Metabolic Response to Dietary Energy Restriction in Women

    by Nancy L. Keim, William F. Horn

    To determine whether prior eating behavior characterized by dietary restraint alters responses in energy expenditure and substrate oxidation associated with a short-term, energy-restricted diet. A repeated-measures, 3-day diet-intervention study of adequate (125 kJ/kg of body weight) or restricted (62.5 kJ/kg) energy intake was conducted with 30 women, 20 to 46 years, BMI 25 to 45 kg/m(2), whose prior eating behavior was "restrained" or "unrestrained." The Eating Inventory (cognitive restraint subscale) was used to measure restrained eating behavior. Energy expenditure and substrate oxidation were measured after a 12-hour fast and during the first and fourth hours after a standard meal. Plasma glucose, nonesterified fatty acids, and insulin were measured at corresponding times. Body composition was determined by total body electrical conductivity. Resting energy expenditure was not affected by 3 days of energy restriction. Short-term energy restriction resulted in lower respiratory-exchange ratios, higher rates of fat oxidation, and lower rates of carbohydrate oxidation. Subjects classified as restrained eaters had higher postprandial respiratory-exchange ratios and carbohydrate-oxidation rates compared with unrestrained eaters. Fasting insulin concentrations were lower in restrained eaters. These effects associated with prior eating behavior were independent of the diet intervention. Metabolic outcomes associated with a 3-day energy-restricted diet (i.e., increased fat oxidation and decreased carbohydrate oxidation) were not affected by prior restrained eating behavior. However, restrained eating behavior was associated with increased carbohydrate oxidation after a mixed meal. This effect of restrained eating behavior may be attributable to increased insulin sensitivity.


  • Conjugated linoleic acid supplementation in humans: Effects on fatty acid and glycerol kinetics

    by Kirsten L. Zambell, William F. Horn, Nancy L. Keim

    Recent studies with mouse adipocytes have shown that dietary conjugated linoleic acid (CLA) may reduce body fat by increasing lipolysis. The present study examined the effect of CLA supplementation on fatty acid and glycerol kinetics in six healthy, adult women who were participating in a controlled metabolic ward study. These women were fed six CLA capsules per day (3.9 g/d) for 64 d following a baseline period of 30 d. The subjects were confined to a metabolic suite for the entire 94‐d study, where diet and activity were controlled and held constant. The rate of appearance (Ra) of glycerol, which indicates lipolytic rates, was similar at baseline and after 4 wk of CLA supplementation at rest (1.87±0.21 and 2.00±0.39 μmol/kg/min, respectively) and during exercise (7.12±0.74 and 6.40±0.99 μmol/kg/min, respectively). Likewise, the Ra of free fatty acids (FFA) was not significantly different after 4 wk of dietary CLA at rest (2.72±0.06 and 2.74±0.12 μmol/kg/min, respectively) or during exercise (6.99±0.40 and 5.88±0.29 μmol/kg/min, respectively). CLA supplementation also had no effect on the percentage of FFA released from lipolysis that were re‐esterified. The apparent rate of FFA re‐esterification was 65.2±4.2% at rest and 32.1±3.44% during exercise. Four weeks of CLA supplementation had no significant effect on fatty acid or glycerol metabolism in healthy, weight‐stable, adult women.


  • Conjugated linoleic acid supplementation in humans: Effects on circulating leptin concentrations and appetite

    by Edward A. Medina, William F. Horn, Nancy L. Keim, Peter J. Havel, Paloma Benito, Darshan S. Kelley, Gary J. Nelson, Kent L. Erickson

    Conjugated linoleic acid (CLA) has been demonstrated to reduce body fat in animals. However, the mechanism by which this reduction occurs is unknown. Leptin may mediate the effect of CLA to decrease body fat. We assessed the effects of 64 d of CLA supplementation (3 g/d) on circulating leptin, insulin, glucose, and lactate concentrations in healthy women. Appetite was assessed as a physiological correlate of changes in circulating leptin levels. Analysis of plasma leptin concentrations adjusted for adiposity by using fat mass as a covariate showed that CLA supplementation significantly decreased circulating leptin concentrations in the absence of any changes of fat mass. Mean leptin levels decreased over the first 7 wk and then returned to baseline levels over the last 2 wk of the study in the CLA‐treated group. Appetite parameters measured at around the time when the greatest decreases in leptin levels were observed showed no significant differences between supplementation and baseline determinations in the CLA‐supplemented group or between the CLA and placebo‐supplemented groups. There was a nonsignificant trend for mean insulin levels to increase toward the end of the supplementation period in CLA‐treated subjects. CLA did not affect plasma glucose and lactate over the treatment period. Thus, 64 d of CLA supplementation in women produced a transient decrease in leptin levels but did not alter appetite. CLA did not affect these parameters in a manner that promoted decreases of adiposity.


  • Open Access

    Weight Loss is Greater with Consumption of Large Morning Meals and Fat-Free Mass Is Preserved with Large Evening Meals in Women on a Controlled Weight Reduction Regimen ,

    by Nancy L. Keim, Marta D. Van Loan, William F. Horn, Teresa F. Barbieri, Patrick L. Mayclin

    The purpose of this study was to determine whether meal ingestion pattern [large morning meals (AM) vs. large evening meals (PM)] affects changes in body weight, body composition or energy utilization during weight loss. Ten women completed a metabolic ward study of 3-wk weight stabilization followed by 12 wk of weight loss with a moderately energy restricted diet [mean energy intake ± SD = 107 ± 6 kJ/(kg⋅d)] and regular exercise. The weight loss phase was divided into two 6-wk periods. During period 1, 70% of daily energy intake was taken as two meals in the AM (n = 4) or in the PM (n = 6). Subjects crossed over to the alternate meal time in period 2. Both weight loss and fat-free mass loss were greater with the AM than the PM meal pattern: 3.90 ± 0.19 vs. 3.27 ± 0.26 kg/6 wk, P < 0.05, and 1.28 ± 0.14 vs. 0.25 ± 0.16 kg/6 wk, P < 0.001, respectively. Change in fat mass and loss of body energy were affected by order of meal pattern ingestion. The PM pattern resulted in greater loss of fat mass in period 1 (P < 0.01) but not in period 2. Likewise, resting mid-afternoon fat oxidation rate was higher with the PM pattern in period 1 (P < 0.05) but not in period 2, corresponding with the fat mass changes. To conclude, ingestion of larger AM meals resulted in slightly greater weight loss, but ingestion of larger PM meals resulted in better maintenance of fat-free mass. Thus, incorporation of larger PM meals in a weight loss regimen may be important in minimizing the loss of fat-free mass.


  • Effects of Dietary n-3 Fatty Acid Supplementation in Men with Weight Loss Associated with the Acquired Immune Deficiency Syndrome: Relation to Indices of Cytokine Production

    by Marc K. Hellerstein, Kenneth Wu, Michael McGrath, Dennis Faix, Dianne George, Cedric H. L. Shackleton, William Horn, Rebeccah Hoh, Richard A. Neese

    Cytokines may be involved in weight loss and disturbances of metabolism associated with human immunodeficiency virus (HIV) infection. Dietary n-3 fatty acids reduce the production of interleukin-1 (IL-1) and tumor necrosis factor (TNF) by peripheral blood mononuclear cells (PBMC) in normal humans and prevent IL-1 and TNF anorexia in animals. Accordingly, we studied the nutritional and metabolic effects of a 10-week trial of dietary fish oil (MaxEPA 18 g/day) in men with weight loss due to acquired immune deficiency syndrome (AIDS). Twenty men were enrolled, and 16 completed the 10-week supplementation period. Prior weight loss was 13.7 ± 1.8 kg (17.4 ± 1.6% body weight, means ± SE). Food intake, body composition, blood chemistries, serum cytokine concentrations, in vitro production of IL-1 and TNF by PBMC, and clinical course were followed. A subset of subjects (n = 12) underwent stable isotope infusions to measure de novo hepatic lipogenesis (DNL), an in vivo metabolic index that is influenced by cytokine presence and has previously been found to be elevated in AIDS. An unsupplemented group of men with AIDS wasting (10.4 ± 2.4 kg weight loss, 13.1 ± 2.2% body weight) was monitored for 10 weeks as controls. Baseline food intake (2,395 ± 177 kcal/day and 95.1 ± 7.2 g protein/day), body weight, percent fat, and fat-free mass were unchanged over the 10-week supplementation period. Serum triglycerides were reduced in hypertriglyceridemic subjects, confirming compliance with fish oil supplementation and suggesting that their hypertriglyceridemia was at least in part due to overproduction. Serum TNF and IL-1 were undetectable before or after fish oil supplementation. Serum interferon α (IFN) was measurable but did not change. In vitro production of IL-1 and TNF by PBMC was markedly reduced both at baseline and after fish oil supplementation in this population, even in the presence of new AIDS complications, compared with normal controls. The metabolic measurement DNL fell and weight was gained (2.1 ± 1.3 kg) in subjects who did not develop new AIDS-related complications, but further increases in DNL and further weight loss were observed in subjects who developed a new AIDS complication (p < 0.05 for interaction between new complication and change in DNL). No changes in body weight, food intake, serum triglycerides, serum cytokines, or DNL were observed in the unsupplemented group. We conclude that fish oil is a weak anticytokine agent that is unable to overcome the metabolic and nutritional consequences of acute AIDS-related complications but may exert a clinical anticytokine effect in stable AIDS patients. Cytokine production by PBMC is not a useful or reliable marker of in vivo cytokine activity in AIDS patients with weight loss. In contrast, an integrative functional index that is sensitive to cytokine presence in tissues (hepatic DNL) correlated with clinical response. These findings are relevant to the design of future studies of more potent anticytokine agents, such as thalidomide.